2021 annual financial data

Lexeo Therapeutics, Inc. 2021 Net margin

Lexeo Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -3,055.04%.

Operating income was -50,637,000 USD and net income was -50,622,000 USD.
Operating cash flow was -44,182,000 USD.

Get free Lexeo Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,657,000 USD
Operating income
-50,637,000 USD
Net income
-50,622,000 USD
Operating cash flow
-44,182,000 USD